NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/15/25 | SCHEDULE 13G/A | Statement of Beneficial Ownership by Certain Investors |
|
9 | |
| 05/15/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
   |
62 |
| 05/14/25 | 8-K | Current report |
|
|
6 |
| 05/13/25 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
|
4 | |
| 05/05/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/05/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/05/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/29/25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 04/29/25 | DEF 14A | Definitive proxy statements |
|
|
46 |
| 04/18/25 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
|
46 |